Abstract Background In vivo genome editing offers a long-term therapeutic approach for monogenic diseases by directly modifying genetic sequences
The Guardian also reported on Phase 3 trial results showing substantial average weight loss among adults with obesity or overweight, while noting common gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
Available Preparations In the UK, several GLP-1 receptor agonists are licensed and available through the NHS, including: Semaglutide (Ozempic, Wegovy, and oral Rybelsus) Dulaglutide (Trulicity) Liraglutide (Victoza, Saxenda) Exenatide (Byetta, Bydureon) Lixisenatide (Lyxumia) Most are administered via subcutaneous injection, with dosing frequencies ranging from twice daily to once weekly, depending on the specific formulation
Understanding Hyperpigmentation Hyperpigmentation occurs when certain areas of the skin become darker than the surrounding areas, often caused by sun exposure, hormonal changes, or skin injuries